Search results for "Hepatitis C"
Did you mean "hepatitis"?
Sort by: Relevance | Newest | OldestPatients had high adherence to HCV treatment delivered in opioid agonist therapy programs
The hepatitis C virus (HCV) treatment completion rate was 97% among all participants, including those actively using drugs.
https://gastroenterology.acponline.org/archives/2019/04/26/6.htm
26 Apr 2019
HCV-infected kidney transplants appear cost-effective in recipients with HCV
Transplanting a hepatitis C virus (HCV)-infected kidney and then administering HCV treatment was more effective and cost less than transplanting an HCV-uninfected kidney after HCV treatment in HCV-infected patients, mainly because the waiting list for uninfected kidneys is longer.
https://gastroenterology.acponline.org/archives/2018/07/27/6.htm
27 Jul 2018
High HCV cure rate seen with FDA-approved direct-acting antiviral regimens
Six of the direct-acting antiviral (DAA) regimens yielded sustained virologic response rates above 95% in patients who had hepatitis C virus (HCV) genotype 1 without cirrhosis, including those with HIV co-infection.
https://gastroenterology.acponline.org/archives/2017/03/24/7.htm
24 Mar 2017
Spotlight on The Liver Meeting
Highlights from the American Association for the Study of Liver Diseases' annual meeting, held virtually this past weekend, included insights on COVID-19 and the liver and a conversation with the winners of the Nobel Prize in Physiology or Medicine 2020, who discovered hepatitis C virus.
https://gastroenterology.acponline.org/archives/2020/11/20/5.htm
20 Nov 2020
HCV treatment was successful among patients who used injection drugs
The open-label, single-arm, industry-funded phase 4 trial included patients who had used injection drugs within six months and had chronic hepatitis C virus (HCV), recruited at 19 sites in seven countries.
https://gastroenterology.acponline.org/archives/2018/01/26/2.htm
26 Jan 2018
Transplant of HCV-infected kidneys to HCV-negative recipients yields good outcomes at 12 months
The study authors concluded that their results should encourage efforts to increase use of hepatitis C virus (HCV)-infected kidneys and called for larger confirmatory trials.
https://gastroenterology.acponline.org/archives/2018/08/24/7.htm
24 Aug 2018
MKSAP Quiz: New-onset ascites
This month's quiz asks readers to determine appropriate management for a 55-year-old man with hepatitis C-related cirrhosis who is hospitalized for new-onset ascites.
https://gastroenterology.acponline.org/archives/2018/11/27/4.htm
27 Nov 2018
Spotlight on hepatocellular cancer
One recent study assessed occurrence of hepatocellular carcinoma in patients with hepatitis C-associated cirrhosis, while another looked at the effect of hepatobiliary cancer surveillance on outcomes in patients with primary sclerosing cholangitis.
https://gastroenterology.acponline.org/archives/2018/04/27/6.htm
27 Apr 2018
Aspirin use is associated with reduced risk for hepatocellular carcinoma
The findings of a recent meta-analysis provide support for an association between aspirin use and reduced risk for hepatocellular carcinoma but do not warrant use of aspirin as prophylaxis, and more research is needed, an ACP Journal Club commentary said.
https://gastroenterology.acponline.org/archives/2022/07/22/8.htm
22 Jul 2022
HCV treatment appeared successful for patients who hadn't responded to previous direct-acting antivirals, industry-funded study finds
The study included two phase 3 trials: POLARIS-1, in which patients with chronic hepatitis C virus (HCV) had previously taken a regimen containing an NS5A inhibitor, and POLARIS-4, in which patients had previously received a direct-acting antiviral agent regimen that did not include an NS5A inhibitor.
https://gastroenterology.acponline.org/archives/2017/06/23/3.htm
23 Jun 2017